One of the first candidates identified from the AmpikaPhytobase™ is NDL-101. It is a pain relief medicine in an over the counter natural product formulation. NDL-101's efficacy is apparent from phase II trials undertaken by NeuroDiscovery Ltd.

Ampika is seeking further collaborating partners to commercialise plant formulations from among the 500 plants in the AmpikaPhytobase™. Of these candidate plants, 300 are detailed and cross-checked and, of these, 150 are verified taxonomically. In-depth understanding of the medicinal use of these plants by local indigenous experts assists Ampika in identifying how to apply these natural medicines in a global market. Experts state that over 50% of prescription drugs are derived from chemicals first identified in plants. Potential collborating partners are encouraged to contact Ampika to discuss opportunities for partnerships.

med plant 44

Share This Page
Latest News

Dr Freedman to go to the Peruvian Amazon in February 2012 to visit the Live Pharmacy more>>